This three-year Bachelor of Science (Honours) program in Pharmacology and Innovative Therapeutics, offered jointly by the School of Biological and Behavioural Sciences and the School of Medicine and Dentistry within the Faculty of Science and Engineering, focuses on the principles of pharmacology with a strong emphasis on the development of novel therapeutic strategies. The curriculum likely covers traditional pharmacology topics alongside cutting-edge areas such as gene therapy, immunotherapy, and targeted drug delivery. Students will gain an understanding of drug action, disease mechanisms, and the innovative approaches driving the future of therapeutics.

Career options for graduates with a BSc (Hons) in Pharmacology and Innovative Therapeutics can include roles in the pharmaceutical and biotechnology industries (drug discovery and development, preclinical research, clinical trials), research institutions (developing novel therapies), regulatory affairs (focused on innovative treatments), and potentially in science communication or specialized sales roles. The program's emphasis on innovation provides a strong foundation for contributing to the future of medicine.

Queen Mary University of London is a member of the UK's prestigious Russell Group, known for its research-intensive learning environment and high academic standards, particularly within its Faculty of Science and Engineering and its Schools of Biological and Behavioural Sciences and Medicine and Dentistry, which are at the forefront of biomedical research. The university has a strong background in social justice, social mobility, and embracing diversity, creating an inclusive and supportive environment for students. As a campus university located in London, regularly voted the world's #1 student city, it offers a vibrant and well-connected student experience with access to numerous opportunities in the life sciences sector.